XML 12 R1.htm IDEA: XBRL DOCUMENT v3.6.0.2
Document and Entity Information - shares
 3 Months Ended
Mar. 31, 2016
May 05, 2016
Document And Entity Information    
Entity Registrant Name ATOSSA GENETICS INC  
Entity Central Index Key 0001488039  
Document Type 10-Q/A  
Trading Symbol ATOS  
Document Period End Date Mar. 31, 2016  
Amendment Flag true  
Amendment Description

EXPLANATORY NOTE

 

This Amendment No. 1 to the Quarterly Report on Form 10-Q (the “Amended Form 10-Q”) of Atossa Genetics Inc. (the “Company”) amends the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2016, filed with the Securities and Exchange Commission on May 5, 2016 (the “Original Form 10-Q”) to correct an inadvertent error in the weighted average shares outstanding in the financial statements for the three months ended March 31, 2016. The Company incorrectly stated the weighted average number of shares outstanding – basic and diluted for the three months ended March 31, 2016 as 31,511,623, rather than the correct number of 35,741,357. As a result, the following items in the original filing have been amended:

  

Part I, Item 1. Financial Statements, Condensed Consolidated Statements of Operations (unaudited);

Part I, Item 1. Notes to Condensed Consolidated Financial Statement (Unaudited), Note 10 - Net Loss Per Share; and

Part I, Item 4. Controls and Procedures.

  

In accordance with applicable generally accepted accounting principles, the Company has calculated and recognized adjustments accordingly. The following table shows the effect of the restatement on the Company’s financial statements for the three months ended March 31, 2016:

 

    For the Three Months Ended
March 31, 2016		  
   

Previously

Reported

     Restated  
Weighted average common shares outstanding used to compute income (loss) per share, basic and diluted     31,511,623       35,741,357  

  

Except as specifically noted above, this Form 10-Q/A does not modify or update the Original 10-Q or modify or update any related or other disclosures as originally filed, other than as required to reflect the effects of the amendment discussed above. Management has discussed these matters set forth above with the Company’s independent registered public accounting firm. On March 20, 2017, the Company’s Chief Financial Officer concluded that the financial statements and other financial data at and for the three months ended March 31, 2016, as reported in the Original Form 10-Q, should not be relied upon because of the error described above which has been corrected in the Amended Form 10-Q. Additionally, investors, analysts and other persons should not rely upon any press releases, investor presentations or other communications that relate to that information.

  
Current Fiscal Year End Date --12-31  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filer No  
Entity's Reporting Status Current Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   38,823,464
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2016